Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2001, p. 560-563, Vol. 39, No. 2
Departament de Farmacologia i
Terapèutica1 and Departament de
Medicina i Cirugia Animals,3 Universitat
Autònoma de Barcelona, Bellaterra, Barcelona, and Centre
Sanitari Municipal, Palma de Mallorca,2 Spain
Received 31 July 2000/Returned for modification 1 November
2000/Accepted 30 November 2000
We studied and compared the prevalence of Leishmania
infection and the seroprevalence and the prevalence of canine
leishmaniasis in an area where canine leishmaniasis is endemic. One
hundred dogs living on the island of Mallorca (Spain) were studied. In this study, we clinically examined each dog for the presence of symptoms compatible with leishmaniasis, determined the titer of anti-Leishmania antibodies, and investigated the presence
of Leishmania DNA by PCR in skin, conjunctiva, and bone
marrow samples of each dog. The prevalence of the disease and the
seroprevalence were 13 and 26%, respectively. In 63% of the dogs,
Leishmania DNA could be detected by PCR in at least one of
the tissues studied. The results of positive PCR in the bone marrow,
the conjunctiva, and the skin were 17.8, 32, and 51%, respectively.
The prevalence of the infection, 67%, was calculated using all animals
that were seropositive and/or positive by PCR with any tissue. The
results showed that the majority of dogs living in an area where canine leishmaniasis is endemic are infected by Leishmania and
that the prevalence of infection is much greater than the prevalence of overt Leishmania-related disease.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.560-563.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Prevalence of Leishmania infantum
Infection in Dogs Living in an Area of Canine Leishmaniasis Endemicity
Using PCR on Several Tissues and Serology
*
Corresponding author. Mailing address: Departament de
Farmacologia i Terapèutica, Facultat de Veterinària,
Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
Phone: 34 93-581-2062. Fax: 34 93-581-2006. E-mail:
lsolano{at}quiro.uab.es.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|